e-learning
resources
Paris 2018
Sunday, 16.09.2018
COPD around the world
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics of "frequent exacerbators" in mild to moderate COPD patients.
H. Choi (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea)
Source:
International Congress 2018 – COPD around the world
Session:
COPD around the world
Session type:
Thematic Poster
Number:
763
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Choi (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), K. Yoo (Seoul, Republic of Korea), C. Rhee (Seoul, Republic of Korea). Characteristics of "frequent exacerbators" in mild to moderate COPD patients.. 763
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Can we consider the "frequent exacerbator" a reliable COPD phenotype?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Frequent exacerbators among patients with COPD - prevalence and stability
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Predictors of severe exacerbations in patients with moderate and severe asthma
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Muscle dysfunction as a systemic marker of risk for exacerbation of COPD patients: the Spanish "IMAGIM study"
Source: Eur Respir J 2004; 24: Suppl. 48, 2s
Year: 2004
LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Frequent COPD exacerbators are not a stabile phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Characteristics of patients with frequent EXACT-PRO defined exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
LATE-BREAKING ABSTRACT: The infrequent "frequent" exacerbator: An analysis of the SPIROMICS cohort
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
What are the differences between moderate and severe COPD exacerbation groups?
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Comparison of small airways disease measures between frequent and infrequent COPD exacerbators
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019
Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study
Source: Eur Respir J 2006; 28: Suppl. 50, 549s
Year: 2006
Markers of T2-inflammation in patients with severe asthma and concomitant COPD
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Transcriptomic footprint of COPD patients with well-defined frequent severe exacerbations.
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Are severe and moderate exacerbations different entities?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept